This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Oncocross Co., Ltd.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Innovations by Yi-Rang Kim in Pharmaceutical Composition
Introduction
Yi-Rang Kim is an accomplished inventor based in Sejong, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of muscular disorders and cancer. With a total of 4 patents to his name, his work is paving the way for innovative therapeutic solutions.
Latest Patents
One of Yi-Rang Kim's notable patents is a composition for the treatment of muscular disorders. This invention relates to a pharmaceutical composition aimed at preventing or treating muscular diseases. The composition comprises dimenhydrinate, harmol, and/or calcium pantothenate as active ingredients. The individual application of these components promotes myoblast proliferation and differentiation. Notably, the combination of these ingredients synergistically enhances their effects, making them useful for the prevention or treatment of muscular diseases, particularly sarcopenia.
Another significant patent by Kim focuses on inhibiting cancer metastasis and treating cancer. This invention highlights the anticancer and metastasis-inhibiting effects achieved through treatment with chlorphenesin, chloroquine, and chloropyrazine, either alone or in combination. Each of these compounds has demonstrated the ability to kill cancer cells and inhibit their proliferation and metastasis. The synergistic effect of their combination further enhances their efficacy in preventing or treating cancer.
Career Highlights
Yi-Rang Kim is currently associated with Oncocross Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments that address critical health issues.
Collaborations
Throughout his career, Kim has collaborated with notable colleagues, including Jin-woo Choi and Jin-Woo Choi. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Yi-Rang Kim's contributions to pharmaceutical innovations are noteworthy, particularly in the areas of muscular disorders and cancer treatment. His patents reflect a dedication to improving health outcomes through scientific research and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile